ArticleEvidence-based complementary and alternative medicine : eCAM2022

Aberrant Expression TFR1/CD71 in Gastric Cancer Identifies a Novel Potential Prognostic Marker and Therapeutic Target.

Jielu Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.